Answers are grounded in this paper and cite their sources.
Accumulating evidence suggest an active role of β cells in T1D pathogenesis. Based on such observation several studies aimed in mapping T1D risk variants acting at the β cell level. Such studies unravel T1D risk loci shared with type 2 diabetes (T2D) and T1D risk variants potentially interfering with β-cell responses to external stimuli. The characterization of regulatory genomics maps of disease-relevant states and cell types can be used to elucidate the mechanistic role of β cells in the pathogenesis of T1D.
No takes yet. Share an insight, caveat, or question.
Ramos-Rodríguez et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: